S
Sumitomo Chemical Co Ltd
TSE:4005
Sumitomo Chemical Co Ltd
TSE:4005
Price:
344.3
JPY
Market Closed
Market Cap:
570.6B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Sumitomo Chemical Co Ltd
344.3
0.0 (0%)
| 52 Week Range |
298.8
431.6
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Sumitomo Chemical Co Ltd
Balance Sheet
Balance Sheet Decomposition
Sumitomo Chemical Co Ltd
Sumitomo Chemical Co Ltd
| Current Assets | 1.7T |
| Cash & Short-Term Investments | 323.8B |
| Receivables | 550.8B |
| Other Current Assets | 796.5B |
| Non-Current Assets | 2T |
| Long-Term Investments | 551.5B |
| PP&E | 811.4B |
| Intangibles | 498.6B |
| Other Non-Current Assets | 186.4B |
| Current Liabilities | 1.3T |
| Accounts Payable | 527.6B |
| Short-Term Debt | 299.3B |
| Other Current Liabilities | 459.4B |
| Non-Current Liabilities | 1.5T |
| Long-Term Debt | 1T |
| Other Non-Current Liabilities | 474.5B |
Balance Sheet
Sumitomo Chemical Co Ltd
Sumitomo Chemical Co Ltd
Currency: JPY
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
112 258
|
136 554
|
193 295
|
231 929
|
201 678
|
180 648
|
360 918
|
365 429
|
305 844
|
217 449
|
|
| Cash Equivalents |
112 258
|
136 554
|
193 295
|
231 929
|
201 678
|
180 648
|
360 918
|
365 429
|
305 844
|
217 449
|
|
| Short-Term Investments |
111 301
|
81 041
|
5 652
|
6 720
|
5 352
|
8 945
|
12 814
|
23 991
|
31 237
|
31 338
|
|
| Total Receivables |
454 137
|
413 190
|
503 509
|
530 571
|
549 992
|
570 413
|
652 616
|
720 422
|
603 161
|
620 022
|
|
| Accounts Receivables |
454 137
|
413 190
|
460 487
|
480 332
|
505 568
|
501 872
|
582 429
|
661 821
|
538 861
|
547 931
|
|
| Other Receivables |
0
|
0
|
43 022
|
50 239
|
44 424
|
68 541
|
70 187
|
58 601
|
64 300
|
72 091
|
|
| Inventory |
439 880
|
402 255
|
397 400
|
446 801
|
489 266
|
492 391
|
511 529
|
651 358
|
744 474
|
709 637
|
|
| Other Current Assets |
143 330
|
154 889
|
41 022
|
38 797
|
44 935
|
58 509
|
46 594
|
51 442
|
78 168
|
97 436
|
|
| Total Current Assets |
1 260 906
|
1 187 929
|
1 140 878
|
1 254 818
|
1 291 223
|
1 310 906
|
1 584 471
|
1 812 642
|
1 762 884
|
1 675 882
|
|
| PP&E Net |
694 435
|
642 166
|
644 059
|
675 745
|
735 918
|
778 417
|
793 500
|
823 022
|
829 355
|
796 526
|
|
| PP&E Gross |
694 435
|
642 166
|
644 059
|
675 745
|
735 918
|
778 417
|
793 500
|
823 022
|
829 355
|
796 526
|
|
| Accumulated Depreciation |
1 926 798
|
1 859 237
|
2 027 729
|
2 064 688
|
2 103 645
|
2 128 624
|
2 215 997
|
2 335 687
|
2 449 764
|
2 578 951
|
|
| Intangible Assets |
108 844
|
104 615
|
232 754
|
232 629
|
216 664
|
465 646
|
450 172
|
471 109
|
403 996
|
272 921
|
|
| Goodwill |
95 249
|
82 647
|
120 548
|
122 849
|
126 838
|
200 416
|
220 295
|
244 517
|
266 868
|
263 757
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
521 660
|
472 066
|
562 870
|
611 258
|
622 436
|
752 699
|
772 629
|
764 867
|
716 095
|
732 735
|
|
| Other Long-Term Assets |
124 536
|
102 620
|
177 084
|
171 386
|
178 539
|
146 003
|
169 187
|
191 994
|
186 305
|
192 997
|
|
| Other Assets |
95 249
|
82 647
|
120 548
|
122 849
|
126 838
|
200 416
|
220 295
|
244 517
|
266 868
|
263 757
|
|
| Total Assets |
2 880 396
N/A
|
2 662 150
-8%
|
2 878 193
+8%
|
3 068 685
+7%
|
3 171 618
+3%
|
3 654 087
+15%
|
3 990 254
+9%
|
4 308 151
+8%
|
4 165 503
-3%
|
3 934 818
-6%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
258 161
|
205 188
|
415 774
|
484 872
|
480 985
|
433 758
|
520 801
|
549 670
|
513 835
|
540 631
|
|
| Accrued Liabilities |
0
|
31 045
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
147 805
|
126 659
|
210 734
|
162 521
|
164 045
|
372 995
|
155 666
|
179 311
|
328 781
|
393 104
|
|
| Current Portion of Long-Term Debt |
236 334
|
219 351
|
102 895
|
129 401
|
94 770
|
93 532
|
94 723
|
81 969
|
68 122
|
192 801
|
|
| Other Current Liabilities |
198 309
|
207 187
|
226 827
|
252 156
|
265 334
|
262 043
|
319 502
|
362 541
|
367 629
|
316 951
|
|
| Total Current Liabilities |
869 845
|
789 430
|
956 230
|
1 028 950
|
1 005 134
|
1 162 328
|
1 090 692
|
1 173 491
|
1 278 367
|
1 443 487
|
|
| Long-Term Debt |
699 331
|
609 117
|
581 235
|
558 538
|
587 638
|
838 139
|
1 100 677
|
1 089 190
|
1 064 463
|
977 581
|
|
| Deferred Income Tax |
96 253
|
75 490
|
45 743
|
58 404
|
51 171
|
79 528
|
101 854
|
101 299
|
101 164
|
121 146
|
|
| Minority Interest |
326 897
|
323 902
|
303 291
|
325 073
|
353 184
|
468 602
|
462 889
|
483 876
|
317 997
|
198 613
|
|
| Other Liabilities |
96 751
|
97 337
|
179 082
|
170 579
|
175 789
|
181 500
|
214 912
|
242 194
|
232 320
|
228 238
|
|
| Total Liabilities |
2 089 077
N/A
|
1 895 276
-9%
|
2 065 581
+9%
|
2 141 544
+4%
|
2 172 916
+1%
|
2 730 097
+26%
|
2 971 024
+9%
|
3 090 050
+4%
|
2 994 311
-3%
|
2 969 065
-1%
|
|
| Equity | |||||||||||
| Common Stock |
89 699
|
89 699
|
89 699
|
89 699
|
89 699
|
89 699
|
89 699
|
89 699
|
89 810
|
89 938
|
|
| Retained Earnings |
477 445
|
539 490
|
623 508
|
738 882
|
820 454
|
807 959
|
854 538
|
974 382
|
891 552
|
578 175
|
|
| Additional Paid In Capital |
23 695
|
23 475
|
22 105
|
21 688
|
20 438
|
20 784
|
26 882
|
27 089
|
0
|
237
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
8 870
|
0
|
8 228
|
8 296
|
8 322
|
8 329
|
8 334
|
8 343
|
8 349
|
8 355
|
|
| Other Equity |
100 146
|
33 790
|
85 528
|
85 168
|
76 433
|
13 877
|
56 445
|
135 274
|
198 179
|
305 758
|
|
| Total Equity |
791 319
N/A
|
766 874
-3%
|
812 612
+6%
|
927 141
+14%
|
998 702
+8%
|
923 990
-7%
|
1 019 230
+10%
|
1 218 101
+20%
|
1 171 192
-4%
|
965 753
-18%
|
|
| Total Liabilities & Equity |
2 880 396
N/A
|
2 662 150
-8%
|
2 878 193
+8%
|
3 068 685
+7%
|
3 171 618
+3%
|
3 654 087
+15%
|
3 990 254
+9%
|
4 308 151
+8%
|
4 165 503
-3%
|
3 934 818
-6%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
1 634
|
1 634
|
1 635
|
1 635
|
1 635
|
1 635
|
1 635
|
1 635
|
1 635
|
1 636
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
